Although camptothecin (CPT) has been reported to induce apoptosis in various cancer cells, the molecular details of this regulation remain largely unknown. In this study, we demonstrate that BH3-only protein Noxa is upregulated during CPT-induced apoptosis, which is independent of p53. In addition, we show that phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is responsible for Noxa's induction. Luciferase assay and cAMP response element binding protein (CREB) knockdown experiments further demonstrate that CREB is involved in the transcriptional upregulation of Noxa. Moreover, blocking Noxa expression using specific small interfering ribonucleic acid (siRNA) significantly reduces the apoptosis in response to CPT, indicating that Noxa is an essential mediator for CPT-induced apoptosis. Interestingly, antiapoptotic Mcl-1 was also upregulated through PI3K/Akt signaling pathway upon CPT treatment. Using immunoprecipitation assay, Noxa was found to interact with Mcl-1 in the presence or absence of CPT. Knockdown of Mcl-1 expression by short hairpin ribonucleic acid (shRNA) was shown to potentiate CPT-induced apoptosis. Consistently, ectopic overexpression of Mcl-1 rescued cells from apoptosis induced by CPT. Cells coexpressing Noxa and Mcl-1 at different ratio correlates well with the extent of apoptosis, suggesting that the balance between Noxa and Mcl-1 may determine the susceptibility of HeLa cells to CPT-induced apoptosis. Neoplasia (2007) 9, 871-881
Introduction
Apoptosis, also termed as programmed cell death, is an evolutionarily conserved and genetically controlled cellular suicide mechanism [1] . It plays a pivotal role in the regulation of tissue development and homeostasis [2] . Growing evidences have shown that failure or defects in the apoptotic pathway may contribute to the generation of drug resistance [3] . The signaling events leading to apoptosis can be divided into two distinct pathways, i.e., extrinsic and intrinsic cell death pathways [4] . In the intrinsic pathway, mitochondria play a central role in the integration and execution of variety of apoptotic signals. Death signals lead to changes in mitochondrial membrane permeability and the subsequent release of proapoptotic proteins such as cytochrome c [5] . Release of cytochrome c results in the Apaf-1 -mediated activation of initiator caspase-9, which, in turn, activates other effector caspases [6] . Among the components that regulate the intrinsic pathway of apoptosis, Bcl-2 family proteins have been reported to play a major role [7] . By forming heterodimeric complexes at the mitochondria, Bcl-2 family members promote or suppress apoptosis.
Bcl-2 family of proteins can be divided into three groups, i.e., multidomain antiapoptotic proteins (such as Bcl-2, Bcl-x L , and Mcl-1), multidomain proapoptotic proteins (such as Bax, BAK, and Bok), and BH3-only proapoptotic members (e.g., Puma, Noxa, Bid, and Bim) [8] . The proapoptotic BH3-only proteins are the most apical regulators of apoptosis induction. In response to apoptotic stimuli, they will be engaged in transcriptional regulations or posttranslational modifications [9] , ultimately leading to the activation of Bax and BAK. It has been reported that deficiency in Bax and BAK renders cells resistant to apoptosis induced by various apoptotic stimuli [10] [11] [12] , indicating that BH3-only proteins function upstream of Bax and BAK.
Despite the extensive interactions between Bcl-2 family proteins, their respective interaction appears to be selective and specific. For instance, Bim and Puma can bind all of the mutidomain antiapoptotic Bcl-2 family members, whereas Noxa only binds to Mcl-1, but not Bcl-2 and Bcl-x L [13, 14] . On the contrary, Bad interacts with Bcl-2 and Bcl-x L , but not with Mcl-1 [13, 15] . Strikingly, Bid and Bim are able to directly interact with BAK and Bax, resulting in their oligomerization [16 -18] . Recent data showed that, in healthy cells, BAK is functionally inactive due to the formation of BAK -Mcl-1 complex; however, accumulation of Noxa leads to the release of BAK from BAK -Mcl-1 complex and its subsequent activation [19, 20] . In light of these evidences, it is evident that Bcl-2 family members regulate apoptosis using two distinct models. In the first model, Bid-like BH3-only proteins activate apoptosis through direct interaction with Bax and BAK. The second is that Noxa-like BH3-only proteins sensitize apoptosis by binding to and neutralizing the antiapoptotic Bcl-2 family proteins, thereby releasing Bax and BAK.
Camptothecin (CPT) is a specific inhibitor of topoisomerase I and can bind to and stabilize the normally transient DNA -topoisomerase I cleavage complex to collide with the DNA replication fork [21, 22] , resulting in an irreversible double-strand break and eventually cell death [23, 24] . CPT has been reported to induce apoptosis in various cancer cells and some of these cells are lacking in functional p53 [25 -28] , implying that CPT can induce apoptosis in a p53-independent manner.
Although some features characteristic of apoptosis induction by CPT have been already described, the underlying molecular mechanism remains to be fully elucidated. In this study, we showed that CPT was able to transcriptionally upregulate Noxa in a p53-independent manner, in which phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is involved. In addition, we demonstrated that transcription factor cAMP response element binding protein (CREB) was responsible for the Noxa's induction. More importantly, Noxa was shown to be an essential mediator for CPT-induced and caspase-9 -involved apoptosis. Unexpectedly, we found that antiapoptotic Mcl-1 was also upregulated through PI3K/ Akt signaling pathway upon CPT treatment. We demonstrated that Noxa was able to interact with Mcl-1 both in CPT-treated and -untreated cells. Finally, we hypothesized that the ratio of Noxa to Mcl-1 may regulate the shift in the balance of cell fate toward cell death versus survival upon CPT treatment.
Materials and Methods

Reagents and Antibodies
The following antibodies were used in this study: antiMcl-1 and anti-Bax (Santa Cruz Biotechnology, Santa Cruz, CA); anti-caspase-9 (Immunotech, Marseilles, France); antigreen fluorescent protein (GFP) (BD Biosciences, Palo Alto, CA); anti-Flag (Sigma, St Louis, MO); anti-Noxa (Imgenex, San Diego, CA); anti-Puma, anti-AKT, anti-pAKT (S473), and anti-CREB (Cell Signaling Technology, Danvers, MA); and anti-b-actin (Abcam, Cambridge, United Kingdom). Cycloheximide (CHX), camptothecin (CPT), geneticin (G418), doxorubicin, and Hoechst 33342 were purchased from Sigma and LY294002 was purchased from Calbiochem (La Jolla, CA). MitoTracker Red CMXRos was purchased from Molecular Probes (Carlsbad, CA).
Cell Culture and Transfection
Cell lines HeLa and H1299 were cultured in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal bovine serum, 1 Â nonessential amino acid, 100 mg/ml penicillin, 1 Â MEM sodium pyruvate, 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA) at 37jC under an atmosphere of 5% CO 2 in air. Transfection of cells with various mammalian expression constructs by Lipofectamine 2000 (Invitrogen) was according to the methods provided by the manufacturer.
To establish HeLa cell line stably expressing Mcl-1 or control short hairpin ribonucleic acid (shRNA), Mcl-1 or control shRNA expression plasmid (kindly provided by Dr. Gregory J. Gores) was individually transfected into HeLa cells. Fortyeight hours after transfection, clones were selected in culture medium containing 1 mg/ml geneticin (G418) for 3 weeks. The positive clones were further confirmed by Western blot analysis.
RNA Interference (RNAi)
In our study, knock out RNAi system (Clontech Laboratories, Mountain View, CA) was used to knock down CREB protein level. Nineteen-base pair target sequence for CREB was 5V -TAC AGC TGG CTA ACA ATG G-3V. To knock down the endogenous level of Noxa, small interfering ribonucleic acid (siRNA) for Noxa (sc-37305; Santa Cruz Biotechnology) was transfected into HeLa cells according to the manufacturer's instructions. The effect of RNAi on CREB or Noxa protein level was measured by Western blot analysis after 48 hours of transfection.
Western Blot Analysis and Immunoprecipitation
Western blot analyses were performed mainly as described by Mei et al. [29] with following modifications. After incubating with first and second antibodies, blots were developed by electrochemical luminescence (Lumi-Phos WB; Pierce, Rockford, IL). For immunoprecipitation, HeLa cells were lysed in a NP-40 -based lysis buffer (0.2% NP-40, 150 mM NaCl, 20 mM Hepes, pH 7.5, 2 mM EDTA, and 1.5 mM MgCl 2 ) supplemented with protease inhibitor cocktail and 20 mg/ml MG132 for 1 hour on ice. Cytosolic lysate was incubated with anti -Mcl-1 antibody bound to Protein A/G -Sepharose. After incubating at 4jC overnight, the immunoprecipitates were washed five times in lysis buffer and proteins were recovered by boiling the beads in sodium dodecyl sulfate sample buffer and analyzed by Western blot analysis using anti-Noxa antibody.
Protein Stability Assay
After incubating with or without CPT (10 mM) for 9 hours, HeLa cells were further treated with 25 mg/ml CHX for indicated periods of time and were then harvested and analyzed by Western blot analysis as described above.
Reporter Plasmids and Luciferase Assay
The reporter plasmids used in this study (pGL3-Noxa-wt, pGL3-Noxa-mtCRE, and pGL3-Noxa -mtP53) were kindly provided by Dr. C. Lallemand. To analyze the promoter activity of these reporter genes, H1299 cells were transiently transfected with these plasmids. Renilla luciferase reporter plasmid was included as an internal control. Firefly and Renilla luciferase activity were assayed (Dual-Luciferase Reporter Assay System; Promega Corporation, WI) according to the manufacturer's instructions. Tcf/Lef reporter activities were normalized relative to Renilla luciferase activities and presented as means (± SD) of three independent experiments.
Semi-Quantitative Reverse Transcription -Polymerase Chain Reaction (RT-PCR)
For semi-quantitative RT-PCR, HeLa cells were treated either with CPT (10 mM) alone or in combination with LY294002 (40 mM) for 12 hours. Total RNA was isolated using SV Total RNA Isolation System (Promega Corporation) and 0.1 mg of RNA of each sample was used as template. RT-PCR was performed by TaKaRa One-step RNA PCR Kit (TaKaRa Bio Inc., Otsu, Japan) using the following specific primer pairs: Noxa, 5V -ATG CCT GGG AAG AAG GCG CGC-3V and 5V -TCA GGT TCC TGA GCA GAA GAG-3V; b-actin, 5V -GAC CTG ACT GAC TAC CTC ATG AAG AT-3V and 5V -GTC ACA CTT CAT GAT GGA GTT AAG G-3V.
Apoptosis Assay
Apoptosis assay was performed mainly as described previously [30] . Briefly, cells were treated with CPT (10 mM) or in combination with other reagents for the indicated periods of time. The viability of cells was measured by counting the number of apoptotic cells characteristic of aberrant nuclei staining by Hoechst 33342, and was normalized to the number of total cells. Data were presented as means (±SD) of three independent experiments.
Results
CPT Induces Noxa Expression in a p53-Independent Manner
CPT, an inhibitor of topoisomerase I, is known to induce apoptosis in various cancer cells [25 -28] . In accordance with these reports, we also found that CPT was able to induce apoptosis in HeLa cells. After 24 hours of exposure to CPT, HeLa cells were shown to have approximately 40% apoptotic cell death ( Figure 1A , upper part). To evaluate whether caspase-9 activation is involved during CPTinduced apoptosis, Western blot analysis was performed. As shown in Figure 1A , caspase-9 activation became detectable after 3 hours of CPT treatment, indicating that mitochondria apoptotic pathway is truly involved in CPT-induced apoptosis. To further investigate the molecular mechanism underlying CPT-induced apoptosis, we compared the effect of CPT on the expression of three proapoptotic Bcl-2 family members, namely Noxa, Puma, and Bax. As shown in Figure 1B, Noxa was significantly upregulated and its induction was detectable as early as 6 hours following CPT treatment. In contrast, neither Puma nor Bax showed any induction upon CPT treatment, suggesting that Noxa is implicated in playing a specific role during CPT induced apoptosis. Because p53 was previously shown to be upregulated by CPT [31] and Noxa is a direct p53 target gene [19] , we sought to determine whether p53 was required for CPT-dependent induction of Noxa. The effect of CPT on Noxa induction in p53-null H1299 cells has been examined. As shown in Figure 1C , the kinetics of Noxa upregulation by CPT in H1299 cells was similar to that in HeLa cells. Thus, we conclude that Noxa is upregulated by CPT in a p53-independent manner.
PI3K/Akt Signaling Pathway is Responsible for CPT-Induced Noxa Induction
PI3K/Akt pathway has been shown to be activated by various growth factors and play a critical role in cell survival [32, 33] . More specifically, previous data indicated that two types of apoptotic stimuli, i.e., staurosporine and etoposide, were capable of activating the PI3K/Akt pathway [34] , which then stimulates us to inquire whether this signaling pathway can also be activated by CPT. To address this issue, we examined the PI3K-dependent activation of Akt phosphorylation after CPT treatment. HeLa cells were treated with CPT for the indicated periods of time and Akt phosphorylation on serine 473 was used as a read-out of PI3K activity [35] . As shown in Figure 2A , CPT-induced pAkt was increased in a time-dependent manner, peaking at 9 hours. To further determine that the activation of PI3K/Akt pathway indeed contributes to Noxa induction upon CPT treatment, HeLa cells were treated either with CPT alone or in combination with LY294002, a specific PI3K inhibitor, for 12 hours ( Figure 2B ). As was expected, Noxa was significantly induced by CPT, however, addition of LY294002 markedly abrogated CPT-induced Noxa upregulation, indicating Noxa induction is closely correlated with PI3K activity (lane 3 vs 2). Together, these data suggest that PI3K/Akt signaling pathway is responsible for CPT-induced Noxa upregulation.
Noxa is Transcriptionally Upregulated By CPT Treatment, in Which CREB is Involved
Because Noxa is an unstable protein and is subject to proteasome-mediated protein degradation [36 -38] , upregulated level of Noxa induced by CPT could be attributed to either less protein degradation or more RNA transcription. To distinguish between these two possibilities, the half-life of Noxa was compared in the presence and absence of CPT. As shown in Figure 3A , although the protein level of Noxa after CHX treatment was higher in the presence than in the absence of CPT, two patterns of decrease in Noxa in the presence and in the absence of CHX displayed in parallel as shown in Figure 3 (upper panels). In addition, total RNA was extracted from HeLa cells treated either with CPT alone or in combination with LY294002 and a semi-quantitative RT-PCR was performed. As shown in Figure 3B , Noxa mRNA level was increased upon CPT treatment (lane 2 vs lane 1); however, when LY294002 was additionally added, Noxa level was significantly inhibited (lane 3 vs lane 2), implying that Noxa is transcriptionally regulated by CPT through the PI3K/Akt signaling pathway.
Transcription factor CREB was known as a regulatory target for the Akt kinase [39] . Recently, it has been shown that CREB is involved in the induction of Noxa by singlestranded RNA viruses by binding to cAMP-responsive element (CRE) binding site within the Noxa promoter [40] . To address whether CREB is also involved in CPT-induced Noxa induction, a reporter assay was performed. HeLa cells were individually transfected with pGL3 -Noxa -wt, pGL3 -Noxa -mtCRE, or pGL3 -Noxa -mtp53. Twenty-four hours posttransfection, cells were treated with or without CPT for another 15 hours. As shown in Figure 3C -b, CPT was shown to activate the wt-Noxa promoter, whereas mutation in CRE binding site notably diminished the Noxa promoter activity, suggesting that CRE binding site indeed plays an essential role in the stimulation of Noxa gene transcription by CPT treatment. In contrast, mutation in the p53 binding site within the Noxa promoter has little, if any, effect on the activation of the promoter by CPT, which further supports our previous conclusion that CPT-induced Noxa upregulation is independent of p53. Next, we knocked down the expression of the CREB to further confirm its role in CPT-induced Noxa upregulation. As shown in Figure 3D , the induction of Noxa by CPT was proportionally reduced in accordance with knockdown of CREB expression using CREB RNAi (lane 3, top panel vs lane 3, middle panel). These results demonstrate that CREB is involved in the transcriptional upregulation of Noxa induced by CPT.
Noxa is Essential, But Not the Sole Determinant for CPT-Induced Apoptosis
Given that Noxa is upregulated by CPT, we further investigated whether the induction of Noxa contributes to CPTinduced apoptosis. HeLa cells were transfected with control or Noxa-specific siRNA, and at 48 hours posttransfection, . CPT-induced apoptotic cell death resulting from Noxa siRNA -transfected cells was lower than that from control siRNA -transfected cells (6% vs 21% at 12 hours and 12% vs 38% at 24 hours), suggesting that Noxa truly contributes to the CPT-induced cell death. Notably, a marked cleavage of caspase-9, as a marker of apoptosis, occurred more prominently in control siRNA -transfected cells than in Noxa siRNA -transfected cells (lower part, middle panel, lane 1, 3 vs lane 2, 4), further indicating that CPT-induced and Noxa-mediated cell death is through an intrinsic apoptotic pathway.
To examine whether additional protein(s) is (are) involved in regulating CPT-induced apoptosis, HeLa cells were treated with CPT in the absence or presence of CHX. The extent of cell death was measured by direct counting of cells with apoptotic nuclear morphology 12 hours after treatment. Caspase-9 activation was also assessed in CHX-treated or -untreated cells by its proteolytical processing. As shown in Figure 4B -a, in the absence of CHX, CPT treatment resulted in activation of caspase-9 followed by manifestation of apoptotic morphology in f 22% of cells observed (lane 2 vs lane 1). However, inhibition of de nova protein synthesis by CHX significantly augmented caspase-9 activation and increased the CPTinduced apoptotic cell death from 22% to nearly 70%. We noticed that in the presence of CHX, the induction of Noxa by CPT was completely blocked and Noxa became hardly detectable (lower part, top panel, lane 3 vs lane 2). This data implies that CPT-induced apoptosis can take place when Noxa fell to an undetectable level and, logically, extra protein(s) (most likely antiapoptotic proteins) should be involved in this apoptotic induction. To further verify this assumption, HeLa cells were treated with CPT in the absence or presence of LY294002 that was shown to inhibit the Noxa expression ( Figure 2B ). The activation of caspase-9 was measured and apoptotic cell death was calculated 24 hours after treatment. As shown in Figure 4B -b, CPT-induced Noxa induction was almost completely inhibited by LY294002 (lower part, top panel, lane 3 vs lane 2) and additional treatment with LY294002 significantly increased CPT-induced apoptosis by 52% (upper part, lane 3 vs lane 2), which was inconsistent with the previous reports [41, 42] . These results further confirm that Noxa alone cannot fully account for CPT-induced apoptosis and that determinant(s) other than Noxa should be also regulated by the PI3K/Akt signaling pathway.
During performance of this study, we found that CPT upregulated the expression of Mcl-1, one of the antiapoptotic Bcl-2 family proteins, but not Bcl-2 or Bcl-x L (data not shown). As shown in Figure 4C 
Ratio of Noxa to Mcl-1 Regulates Cells' Susceptibility to CPT-Induced Apoptosis
Given that both proapoptotic Noxa and antiapoptotic Mcl-1 are upregulated during CPT-induced apoptosis, it is not unreasonable to suspect that the balance between Noxa and Mcl-1 might be the underlying mechanism in regulating cell death/survival upon CPT treatment. To address this issue, we sought whether there exists an interaction between Noxa and Mcl-1 upon CPT treatment. HeLa cells were treated with or without CPT for 12 hours. Cell lysates were then incubated with either control antibody or anti -Mcl-1 antibody bound to Protein A/G -Sepharose. The immunoprecipitates were recovered and subjected to Western blot analysis using anti-Noxa antibody. As shown in Figure 5A , endogenous Mcl-1 and Noxa indeed interacts with each other both in the presence and in the absence of CPT. If the hypothesis that balance between Noxa and Mcl-1 determines cell fate after CPT treatment was true, we would expect that knockdown of Mcl-1 (or Noxa) would increase (or decrease) the susceptibility to CPT-induced apoptosis. To test this hypothesis, HeLa cells stably expressing control or Mcl-1 shRNA was individually treated with CPT for 12 or 24 hours, and the cell viability was calculated by counting apoptotic cells characteristic of aberrant nuclei. As shown in Figure 5B , effective knockdown of Mcl-1 was observed Cell lysates were then prepared and subjected to Western blot analysis using indicated antibodies. Endogenous actin was used as loading control. Figure 3 . CREB, but not p53, is responsible for the transcriptional upregulation of Noxa upon CPT treatment. (A) After incubation with or without CPT (10 M) for 9 hours, HeLa cells were further treated with CHX (20 g/ml) for indicated times (0, 0.5, 1, 2, and 3 hours) before cell extracts were collected. The protein levels of Noxa at different time points were compared by Western blot analysis using anti-Noxa antibody and endogenous actin was used as loading control. (B) HeLa cells were treated with CPT (10 M) alone or in combination with LY294002 (40 M) for 12 hours. Total RNA was extracted from each of these treated samples and the equal amounts of RNA were used for amplification of Noxa cDNA fragment. -Actin was used as internal control. (C) a. Schematic representation of the Noxa promoter luciferase reporter constructs used in this study. Mutated binding sites are indicated by shaded boxes. b. HeLa cells were transiently transfected with the various reporter plasmids shown in (a). Renilla luciferase plasmid pRL-CMV was also introduced into transfected cells as internal control. Twenty-four hours after transfection, cells were treated with or without CPT (10 M) for another 15 hours. Luciferase activity was measured and plotted after normalizing with respect to Renilla luciferase activity (mean ± SD). (D) a. H1299 cells were individually transfected with either CREB or control shRNA expression plasmid. Forty-eight hours after transfection, cells were treated with or without CPT (10 M) for 12 hours before cell lysates were prepared and subjected to Western blot analysis using indicated antibodies. Endogenous actin was used as loading control. b. Scanning densitometry was performed for each band in the blot indicated in D-a and an image analysis software (Scion Image; Scion, Frederick, MD) was used. Figure 5C, upper part) . A direct correlation was also observed between the cleavage (activation) of caspase-9 and the extent of apoptosis (lower part, top panel). As already described in Figure 4A , knockdown of Noxa is expectedly to reduce the apoptosis induced by CPT. Based on these data, it indicates that the ratio of Noxa to Mcl-1 might be involved in the regulation of cellular apoptotic response to CPT.
To further quantitatively validate this hypothesis, HeLa cells were transiently cotransfected with GFP -Noxa and Flag -Mcl-1 expression plasmids varying in different ratios. As shown in Figure 5D , decreasing the Noxa -to -Mcl-1 ratio from 400/100 to 100/400 concurrently reduces the apoptosis induced by CPT (upper part). Although the increased Mcl-1 level was clearly seen on the blot, the reduction of Noxa, however, is less obvious, which could be because, as the level of Noxa increases, more extensive cell death will occur. This result suggests that the ratio of Noxa to Mcl-1 may indeed regulate cell apoptosis decision to undergo apoptosis versus survival upon CPT treatment.
Discussion
Bcl-2 family proteins have been implicated in playing a major role in regulating the apoptosis pathway [7] , and proapoptotic BH3-only proteins are the most apical regulators of apoptosis induction. Noxa, belonging to proapoptotic BH3-only Bcl-2 family, was reported to be upregulated by phorbol ester, p53, E2F1, hypoxia-inducible factor (HIF)-1a, UV radiation, and other DNA-damaging agents such as etoposide and adriamycin [19,43 -48] . In this study, we demonstrated that CPT was able to induce Noxa expression in a p53-independent manner, despite that p53 was shown to be upregulated and activated by CPT [31] . Further results from Noxa knockdown experiments suggest that Noxa plays an important role in CPT-induced apoptosis. PI3K/Akt pathway was shown to be activated by various growth factors and play a critical role in cell survival [32, 33] . Moreover, recent study has showed that PI3K/Akt pathway can also be activated by staurosporine and etoposide [34] . Similarly, we have demonstrated that CPT was capable of activating PI3K/Akt pathway, which was involved in signaling Noxa induction. Although Noxa was reported to be an unstable protein [36 -38] , we have not yet found that CPT can alter Noxa protein stability. Nevertheless, we showed that Noxa was upregulated by CPT at the transcriptional level, in which CREB is involved. This result is not unconceivable, because CREB has been shown to be a regulatory target for the Akt kinase [39] and, more recently, it was shown that CREB plays a vital role in the induction of Noxa by singlestrand RNA viruses [40] .
PI3K/Akt signaling pathway was known to be involved in the upregulation of Mcl-1 by interleukin-3 [49] . In this report, we demonstrated that, in addition to Noxa, Mcl-1 was also upregulated by CPT involving PI3K/Akt signaling pathway. It has already been reported that Mcl-1 protein level was upregulated in response to DNA-damaging agents other than CPT [50] and, therefore, our observation that CPT mediated Mcl-1 induction is not totally exceptional. However, upregulation of antiapoptotic Mcl-1 in response to apoptotic stimulus CPT may imply two causes. Firstly, CPT-induced Mcl-1 upregulation may represent cell's instinctive survival response to the death stimuli, or alternatively, induction of Mcl-1 may stand for the molecular basis underlying the mechanism of acquired resistance to CPT.
Given that both antiapoptotic protein Mcl-1 and proapoptotic protein Noxa are upregulated by CPT and, moreover, Noxa and Mcl-1 were able to interact with each other not only in CPT-untreated cells but also in CPT-treated cells, we assume that there might be a balance between Noxa and Mcl-1 to affect CPT-induced apoptosis. Knockdown of Mcl-1 is able to significantly potentiate CPT-induced apoptosis, whereas ectopic expression of Mcl-1 is capable of rescuing cells from apoptosis induced by CPT. Cells coexpressing ectopic Noxa and Mcl-1 at desired ratios result in an expected extent of apoptosis. These results indicate that the Noxa/Mcl-1 balance regulates cells' susceptibility to CPT-induced apoptosis. Alves et al. proposed recently that the Noxa/Mcl-1 axis plays an important role in glucose limitation -mediated apoptosis [51] , which further supports our above conclusion. More importantly, data revealed by this study may provide useful information for clinical practice: combination treatment with CPT and Mcl-1 interfering might be therapeutically more effective and beneficial compared to monotherapy with either single agent in cancer chemotherapy. In conclusion, we propose a hypothetical model of Noxa and Mcl-1 in the regulation of CPT-induced apoptosis as shown in Figure 6 .
